CoChat

A comprehensive review of hormonal and biological therapies for endometriosis: latest developments

Open access

The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: Endometriosis is a chronic benign estrogen-dependent disease characterized by the presence of endometriotic glands and stroma outside the uterine cavity. Although combined hormonal contraceptives and progestins, currently available first-line treatments for endometriosis, are efficacious and well tolerated for treating disease-related pain, some women experience partial or no improvement of pain or its recurrence is frequent after discontinuation of the therapies. For these reasons, new drugs are under investigation for the treatment of endometriosis. AREAS COVERED: This review aims to give to the reader a complete and updated overview of hormonal and biological therapies for the treatment of endometriosis, underlining the latest developments in this field of research. EXPERT OPINION: Among the new drugs investigated, late clinical trials on gonadotropin-releasing hormone (GnRH) antagonists and aromatase inhibitors (AIs) have demonstrated the most promising results. For this reason, elagolix, a new GnRH-antagonist, recently received the approval by the Food and Drug Administration (FDA) for treating pain associated to endometriosis. Other drugs with innovative targets have been identified, but the majority of these compounds have only been evaluated in pre-clinical studies or early clinical trials. Thus, a further extensive clinical research is necessary to better elucidate their pharmacologic characteristics, their efficacy, and safety for the treatment of this benign chronic disease.

Overview

Integrity signals

Registry

Crossref · 10.1080/14712598.2019.1581761

Cites

177 of 177 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Citations

Cites

1 retracted

Show all 177 references

Research works printed but not linked: 12

  1. Brown J, 2017, Cochrane Database Syst Rev, 1, CD004753
  2. 10.1111/aogs.12326 · DOI · Paper page
  3. Brown J, 2010, Cochrane Database Syst Rev, CD008475
  4. Miller JD, 1990, Prog Clin Biol Res, 323, 337
  5. Dawood MY, 1990, Prog Clin Biol Res, 323, 253
  6. Agarwal SK, 1997, J Reprod Med, 42, 413
  7. Minaguchi H, 1986, Prog Clin Biol Res, 225, 211
  8. Adamson GD, 1994, Int J Fertil Menopausal Stud, 39, 215
  9. 10.1093/humrep/det457 · DOI · Paper page
  10. Le Bouedec G, 1991, Rev Fr Gynecol Obstet, 86, 407
  11. Wang Y, 2013, Int J Clin Exp Pathol, 6, 2824
  12. Gaytan M, 2006, Histol Histopathol, 21, 541

Cited by

See all 70

Metadata

Authors
Barra, F., Grandi, G., Tantari, M., Scala, C., Facchinetti, F., & Ferrero, S.
Affiliations
  • Ospedale Policlinico San Martino (IT)
  • University of Modena and Reggio Emilia (IT)
Corresponding author
Ferrero, Simone
Venue
Expert Opinion on Biological Therapy
Published
2019-02-27
Volume
19
Issue
4
Pages
343-360
ISSN
  • 1471-2598 (ISSN-L)
  • 1744-7682
OpenAlex
W2913913485
Cited by
69
References
177
Citations by year
2026: 8 · 2025: 3 · 2024: 7 · 2023: 8 · 2022: 16 · 2021: 12 · 2020: 9 · 2019: 5
FWCI
1.47
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • Expert Opinion on Biological Therapy (publishedVersion)
  • PubMed (publishedVersion)
  • CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
  • IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
  • Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
Keywords
endometriosis, hormone therapy, biologic therapy, GnRH antagonist, aromatase inhibitors, elagolix, combined hormonal contraceptives, progestins, endometriosis-associated pain, drug development
MeSH terms
Biological Products, Clinical Trials as Topic, Endometriosis, Female, Hormone Antagonists, Humans, Gonadotropin-Releasing Hormone, Progestins, Estrogen Receptor Modulators, Aromatase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A comprehensive review of hormonal and biological therapies for endometriosis: latest developments. https://app.cochat.ai/papers/10.1080/14712598.2019.1581761
The paper
Barra, F., Grandi, G., Tantari, M., Scala, C., Facchinetti, F., & Ferrero, S. (2019). A comprehensive review of hormonal and biological therapies for endometriosis: latest developments. Expert Opinion on Biological Therapy. https://doi.org/10.1080/14712598.2019.1581761

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.